Redhawk Wealth Advisors, Inc. Halozyme Therapeutics, Inc. Transaction History
Redhawk Wealth Advisors, Inc.
- $675 Million
- Q4 2024
A detailed history of Redhawk Wealth Advisors, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Redhawk Wealth Advisors, Inc. holds 38,035 shares of HALO stock, worth $2.12 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
38,035
Previous 36,768
3.45%
Holding current value
$2.12 Million
Previous $2.1 Million
13.55%
% of portfolio
0.27%
Previous 0.33%
Shares
3 transactions
Others Institutions Holding HALO
# of Institutions
539Shares Held
126MCall Options Held
294KPut Options Held
180K-
Black Rock Inc. New York, NY17.6MShares$983 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$719 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$370 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$227 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$190 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.77B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...